Viking Therapeutics Shows Swing-Trade Upside, but Competition and Dilution Risks Persist
Viking Therapeutics' volatility and upcoming catalysts attract swing traders, but biotech competition, clinical trial uncertainty and the prospect of share dilution create notable investor risks.
Seeking Alpha
2 min read
Stocks
Market Analysis
Biotechnology